Literature DB >> 20534579

Antagonizing inhibition gets NK cells going.

Sumati Rajagopalan1, Eric O Long.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20534579      PMCID: PMC2890822          DOI: 10.1073/pnas.1005636107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

Review 1.  HLA class I recognition by killer cell Ig-like receptors.

Authors:  E O Long; S Rajagopalan
Journal:  Semin Immunol       Date:  2000-04       Impact factor: 11.130

2.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.

Authors:  J C Boyington; S A Motyka; P Schuck; A G Brooks; P D Sun
Journal:  Nature       Date:  2000-06-01       Impact factor: 49.962

Review 3.  Licensing of natural killer cells by self-major histocompatibility complex class I.

Authors:  Wayne M Yokoyama; Sungjin Kim
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

4.  Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.

Authors:  Q R Fan; E O Long; D C Wiley
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

5.  Sensitivity of T cells to antigen and antagonism emerges from differential regulation of the same molecular signaling module.

Authors:  Dennis C Wylie; Jayajit Das; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

6.  Peptide antagonism as a mechanism for NK cell activation.

Authors:  Lena Fadda; Gwenoline Borhis; Parvin Ahmed; Kuldeep Cheent; Sophie V Pageon; Angelica Cazaly; Stavros Stathopoulos; Derek Middleton; Arend Mulder; Frans H J Claas; Tim Elliott; Daniel M Davis; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 7.  On the role of self-recognition in T cell responses to foreign antigen.

Authors:  Irena Stefanova; Jeffrey R Dorfman; Makoto Tsukamoto; Ronald N Germain
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

Review 8.  The Yin and Yang of HLA and KIR in human disease.

Authors:  Smita Kulkarni; Maureen P Martin; Mary Carrington
Journal:  Semin Immunol       Date:  2008-07-16       Impact factor: 11.130

Review 9.  Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells.

Authors:  Nathalie T Joncker; David H Raulet
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

Review 10.  Negative signaling by inhibitory receptors: the NK cell paradigm.

Authors:  Eric O Long
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

View more
  5 in total

Review 1.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

2.  Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.

Authors:  Kuldeep S Cheent; Khaleel M Jamil; Sorcha Cassidy; Mengya Liu; Berenice Mbiribindi; Arend Mulder; Frans H J Claas; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

3.  Spatial Clustering of Receptors and Signaling Molecules Regulates NK Cell Response to Peptide Repertoire Changes.

Authors:  Berenice Mbiribindi; Sayak Mukherjee; Dannielle Wellington; Jayajit Das; Salim I Khakoo
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

Review 4.  Controlling natural killer cell responses: integration of signals for activation and inhibition.

Authors:  Eric O Long; Hun Sik Kim; Dongfang Liu; Mary E Peterson; Sumati Rajagopalan
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

5.  Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.

Authors:  Achim K Moesta; Peter Parham
Journal:  Front Immunol       Date:  2012-11-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.